SINT
Sintx Technologies, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.61
+4.55%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.4M | 1.0M | 1.2M | 2.6M | 601.0K |
| Cost of Revenue | 1.4M | 1.2M | 811.0K | 784.0K | 265.0K |
| Gross Profit | (64.0K) | (201.0K) | 435.0K | 1.8M | 336.0K |
| Operating Expenses | |||||
| R&D Expense | 3.2M | 4.6M | 5.2M | 8.7M | 6.5M |
| SG&A Expense | 9.2M | 6.4M | 4.6M | 5.4M | 5.3M |
| General & Admin Expense | 8.6M | 6.2M | 4.0M | 4.2M | 4.0M |
| Selling & Marketing Expense | 609.0K | 242.0K | 614.0K | 1.1M | 1.3M |
| Other Expenses | (655.0K) | (506.0K) | 4.7M | 1.1M | (105.0K) |
| Total Operating Expenses | 11.7M | 10.5M | 14.5M | 15.2M | 11.7M |
| Cost and Expenses | 13.1M | 11.7M | 15.3M | 16.0M | 11.9M |
| Operating Income (EBIT) | (11.8M) | (10.7M) | (14.0M) | (13.4M) | (11.3M) |
| Non-Operating | |||||
| Interest Income | 122.0K | 175.0K | 107.0K | 135.0K | 23.0K |
| Interest Expense | 39.0K | 52.0K | 29.0K | 2.0K | 17.0K |
| Net Interest Income | 83.0K | 123.0K | 78.0K | 133.0K | 6.0K |
| Other Non-Op Income/Expense | 487.0K | 357.0K | 3.0M | 5.1M | (704.0K) |
| Non-Operating Income (excl Interest) | (526.0K) | (409.0K) | (3.1M) | (5.1M) | 687.0K |
| EBT (Pre-Tax Income) | (11.3M) | (10.4M) | (11.0M) | (8.3M) | (12.0M) |
| Income Tax Expense | 6.7M | 6.7M | — | — | — |
| Bottom Line | |||||
| Net Income | (18.0M) | (17.1M) | (11.0M) | (8.3M) | (12.0M) |
| Earnings from Cont. Ops | (18.0M) | (17.1M) | (11.0M) | (8.3M) | (12.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (18.9M) | (17.1M) | (11.0M) | (13.6M) | (19.3M) |
| Per Share | |||||
| Basic EPS | ($5.47) | ($6.16) | ($14.87) | ($35.43) | ($54.67) |
| Diluted EPS | ($5.41) | ($6.16) | ($15.19) | ($19.42) | ($51.96) |
| Revenue Per Share | $0.28 | $0.37 | $1.67 | $6.84 | $1.99 |
| Shares | |||||
| Basic Shares Outstanding | 4.8M | 2.8M | 744781 | 384011 | 301610 |
| Diluted Shares Outstanding | 4.8M | 2.8M | 744781 | 425211 | 317323 |
| Profitability Metrics | |||||
| EBITDA | (10.7M) | (9.7M) | (9.6M) | (6.6M) | (11.1M) |
| D&A | 537.0K | 662.0K | 1.4M | 1.7M | 963.0K |
| EBIT | (11.2M) | (10.3M) | (11.0M) | (8.3M) | (12.0M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026